Milestones
- Environmental risk factors are important in AE development
- Recognition of the complex interplay between environment and
host-microbe
- Discovery of biomarkers as TARC and the microbiome for AE progression
- Biologics strongly improve symptom severity
- Recognition of the disease diversity is reflected in the variety of
novel therapy targets